Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 41 of 58, showing 10 Applications out of 576 total, starting on record 401, ending on 410

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

401.

ECCT/18/05/02   KINGA Study
    Immunogenetic Modulators of Mucosal Protection from HIV-1: The Kinga Study   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR - Partners in Health Research & Development (PHRD) Thika Site.
 
26-07-2018 View

402.

ECCT/18/04/03   ShangRing vs. Mogen Clamp for EIMC
    Evaluation of the ShangRing vs. Mogen Clamp for Early Infant Male Circumcision in sub-Saharan Africa       
Principal Investigator(s)
1. Richard Lee
2. Mark Barone
Site(s) in Kenya
1. Homa Bay Teaching and Referral Hospital (Homa Bay county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
10-12-2018 View

403.

ECCT/18/04/02   Maternal Influenza Vaccine Study
    Impact of HIV Infection and Malaria Parasitemia on Immunogenicity of Inactivated Influenza Vaccine in Pregnant Women and on Mother-to-Child Vaccine-induced Antibody Transfer   
Principal Investigator(s)
1. Sandra S Chaves
Site(s) in Kenya
1. Siaya County Referral Hospital (Siaya county)
2. Bondo Sub-County Hospital (Siaya county)
 
04-06-2018 View

404.

ECCT/18/04/01   CKAF156 STUDY
    A Phase 2 interventional, multicenter, randomized open-label study to determine the effective and tolerable dose of KAF156 and Lumefantrine Solid Dispersion Formulation in combination, given once daily for 1, 2 and 3-days to adults and children with uncomplicated Plasmodium falciparum malaria.   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. KEMRI CDC (Siaya county)
2. Walter Reed Project (Kisumu county)
 
23-08-2018 View

405.

ECCT/18/03/01   JiPime JiPrEP (HIVST Study)
    HIV self-testing to improve the efficiency of PrEP delivery.   
Principal Investigator(s)
1. Kenneth Kairu Ngure
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA)
 
16-05-2018 View

406.

ECCT/18/01/01   Mal 094
    Efficacy, safety and immunogenicity study of GSK Biologicals’ candidate malaria vaccine (SB257049) evaluating schedules with or without fractional doses, early Dose 4 and yearly doses, in children 5-17 months of age.   
Principal Investigator(s)
1. Aaron Samuels
2. Simon Kariuki
Site(s) in Kenya
1. Siaya County Referral hospital (Siaya county)
2. Ngiya Health Center (Siaya county)
3. Kogelo Health Center (Siaya county)
4. Tingwangi (Siaya county)
5. Mulaha (Siaya county)
6. Nyathengo (Siaya county)
7. Bal Olengo (Siaya county)
 
06-03-2018 View

407.

ECCT/17/11/01   MTN 034
    MTN 034   A Phase 2a Crossover Trial Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population   
Principal Investigator(s)
1. ESTHER MUMBI MAKANGA
Site(s) in Kenya
KISUMU CRS
 
08-02-2018 View

408.

ECCT/17/10/01   Neo-Fosfo
    Intravenous and Oral Fosfomycin in Hospitalised Neonates with Clinical Sepsis: an open-label safety and pharmacokinetics study   
Principal Investigator(s)
1. James A Berkley
Site(s) in Kenya
KEMRI-WTRP
 
18-12-2017 View

409.

ECCT/17/09/04   A5354
    A5354       Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses   
Principal Investigator(s)
1. Brian Baker
Site(s) in Kenya
KISUMU CRS
 
21-03-2018 View

410.

ECCT/17/09/03   A5354
    Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses   
Principal Investigator(s)
1. Deborah Langat
Site(s) in Kenya
Kenya Medical Research Institute Walter Reed Project Clinical Research Centre
 
14-11-2017 View